Sign inCreate account

Report workspace tools

NCT04916067TERMINATEDanonymous

Stoma Closure and Reinforcement (SCAR)-II Trial: A Single Center Pilot Study of the Safety of a Mesh Reinforcement of Ileostomy Closure to Prevent Hernia Formation in Inflammatory Bowel Disease Patients

Sponsor

Source record

Dartmouth-Hitchcock Medical Center

Phase

Source record

Pilot Study (terminated)

Modality

AI-normalized

protein therapy

Target

AI-normalized

Hernia formation prevention in ileostomy closure

Indication / condition

AI-normalized

Ileostomy - Stoma

Intervention

Source record

Mesh Implantation

Source & freshness

Source record

NCT ID

NCT04916067

Original source

ClinicalTrials.gov

Source last updated

Feb 27, 2026

Ingested at

May 30, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT04916067

Title

Stoma Closure and Reinforcement (SCAR)-II Trial: A Single Center Pilot Study of the Safety of a Mesh Reinforcement of Ileostomy Closure to Prevent Hernia Formation in Inflammatory Bowel Disease Patients

Sponsor

Dartmouth-Hitchcock Medical Center

Status

TERMINATED

Phase

Pilot Study (terminated)

Condition raw

Ileostomy - Stoma

Condition normalized

Ileostomy - Stoma

Modality raw

Ileostomy - Stoma

Modality normalized

protein therapy

Target raw

Hernia formation prevention in ileostomy closure

Target normalized

Hernia formation prevention in ileostomy closure

Interventions

Mesh Implantation

Public preview

Source record

The SCAR-II trial aimed to evaluate the safety and effectiveness of a bioresorbable mesh reinforcement technique during ileostomy closure in patients with inflammatory bowel disease. The study was conducted at Dartmouth-Hitchcock Medical Center but was terminated early due to resource constraints, with only 8 participants enrolled.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Stoma Closure and Reinforcement (SCAR)-II Trial: A Single Center Pilot Study of the Safety of a Mesh Reinforcement of Ileostomy Closure to Prevent Hernia Formation in Inflammatory Bowel Disease Patients

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT04916067

Status

TERMINATED

Phase

Pilot Study (terminated)

Sponsor

Dartmouth-Hitchcock Medical Center

Executive brief

Investment-Ready Snapshot

The SCAR-II trial aimed to evaluate the safety and effectiveness of a bioresorbable mesh reinforcement technique during ileostomy closure in patients with inflammatory bowel disease. The study was conducted at Dartmouth-Hitchcock Medical Center but was terminated early due to resource constraints, with only 8 participants enrolled.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 27, 2026
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT04916067

Indication

Ileostomy - Stoma

Modality

protein therapy

Target

Hernia formation prevention in ileostomy closure

Intervention

Mesh Implantation

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.